← All trials
NCT00408512
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2006
- Primary completion
- Dec 31, 2009
- Completion date
- Mar 31, 2010
- First posted
- Dec 7, 2006
- Last posted
- Jun 27, 2011
- Enrollment
- 2500
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Naples Frederico IILead sponsor
- Agenzia Italiana del FarmacoCollaborator
- University of Naples Frederico IISponsor investigator
- University of Naples Frederico IIStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.